Akshay Vaishnaw, EVP, Chief Medical Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 10,625 shares at $69.33 ($742K) on 2014-06-17, disclosed to the SEC on 2014-06-19.
Scheduled sale ($742k) by EVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.33 | 2,498 | $173K | 23.3% |
| 2 | $69.97 | 8,127 | $569K | 76.7% |
| Total | $69.82 avg | 10,625 | $742K | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |